EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer

Rushi Patel iD, Aman M Patel iD, Lucy Revercomb, Vivienne Qie, Christopher C Tseng iD, Soly Baredes, Richard Chan Woo Park

The Laryngoscope · 2024

DOI: 10.1002/lary.31588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Rushi Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Cleveland Clinic College of Medicine, Cleveland, Ohio, U.S.A. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Hospitals, High-Volume. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Changing location of postoperative radiotherapy (PORT) after treatment at a high‐volume facility (HVF) is associated with worse survival in various head and neck cancers. Our study investigates this relationship in salivary gland cancer (SGC).

Methods

The 2004–2016 National Cancer Database was queried for all cases of adult SGC treated with surgery and PORT with or without adjuvant chemotherapy. Patients with multiple cancer diagnoses, metastatic disease, or unknown PORT facility were excluded. Reporting facilities with >95th percentile annual case volume were classified as HVFs, the remainder were classified low‐volume facilities (LVFs).

Results

A total of 7885 patients met inclusion criteria, of which 418 (5.3%) were treated at an HVF. Patients treated at an HVF had higher rates clinical nodal positivity (18.2% vs. 14.0%, p < 0.001) and clinical T3/T4 (27.3% vs. 20.7%, p = 0.001) disease. Patients at HVFs changed facility for PORT at lower rates (18.9% vs. 24.5%, p = 0.009). Patients treated at an HVF had higher 5‐year overall survival (5‐OS) than those treated at an LVF (79.0% vs. 72.0%, p = 0.042). Patients treated at an HVF that changed PORT facility had worse 5‐OS (60.8% vs. 83.2%, p < 0.001). Radiation facility change was an independent predictor of worse survival in patients treated at an HVF (HR: 8.99 [3.15–25.67], p < 0.001) but not for patients treated at a LVF (HR: 1.11 [0.98–1.25], p = 0.109).

Conclusions

Patients treated at an HVF changing facility for PORT for SGC experience worse survival. Our data suggest patients treated surgically at an HVF should be counseled to continue their PORT at the same institution. Level of Evidence 3 Laryngoscope , 134:4935–4946, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsHospitals, High-VolumeHumansFemaleMaleMiddle AgedAgedRadiotherapy, AdjuvantHospitals, Low-VolumeRetrospective StudiesSurvival RateAdultUnited StatesDatabases, Factual

Stichwörter der Autor:innen

NCDBSalivary Gland Cancerfacility volumepostoperative radiation therapysurvival

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Cleveland Clinic College of Medicine, Cleveland, Ohio, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, U.S.A.

ORCID-Profile: Rushi Patel, Aman M Patel, Christopher C Tseng

Zitieren

APA

Patel, R., Patel, A. M., Revercomb, L., Qie, V., Tseng, C. C., Baredes, S., & Park, R. C. W. (2024). Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer. The Laryngoscope. https://doi.org/10.1002/lary.31588

Vancouver

Patel R, Patel AM, Revercomb L, Qie V, Tseng CC, Baredes S, et al. Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer. The Laryngoscope. 2024. doi:10.1002/lary.31588

BibTeX
@article{Patel2024,
  author = {Patel, Rushi and Patel, Aman M and Revercomb, Lucy and Qie, Vivienne and Tseng, Christopher C and Baredes, Soly and Park, Richard Chan Woo},
  title = {Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31588}
}
Kostenlos starten →